|
Caribou Biosciences, Inc.
|
-1.38 USD
|
43.478%
|
|
Inhibikase Therapeutics, Inc.
|
-3.57 USD
|
78.151%
|
|
Alaunos Therapeutics, Inc.
|
-21.97 USD
|
96.45%
|
|
Viracta Therapeutics, Inc.
|
-1.32 USD
|
40.909%
|
|
Phathom Pharmaceuticals, Inc.
|
-3.93 USD
|
80.153%
|
|
C4 Therapeutics, Inc.
|
-2.67 USD
|
70.787%
|
|
Agenus Inc.
|
-13.75 USD
|
94.327%
|
|
Fortress Biotech, Inc.
|
-8.47 USD
|
90.791%
|
|
GlycoMimetics, Inc.
|
-0.58 USD
|
-34.483%
|
|
Novavax, Inc.
|
-5.41 USD
|
85.582%
|
|
Keros Therapeutics, Inc.
|
-5.20 USD
|
85.0%
|
|
Eton Pharmaceuticals, Inc.
|
-0.04 USD
|
-2036.986%
|
|
CARGO Therapeutics, Inc. Common Stock
|
-2.38 USD
|
67.227%
|
|
Entrada Therapeutics, Inc.
|
-0.20 USD
|
-290.0%
|
|
Akebia Therapeutics, Inc.
|
-0.28 USD
|
-178.571%
|
|
Alnylam Pharmaceuticals, Inc.
|
-3.52 USD
|
77.841%
|
|
AlloVir, Inc.
|
-1.83 USD
|
57.377%
|
|
Aptorum Group Limited
|
-0.62 USD
|
-25.806%
|
|
Ardelyx, Inc.
|
-0.30 USD
|
-160.0%
|
|
Bicycle Therapeutics plc
|
-5.08 USD
|
84.646%
|
|
BioXcel Therapeutics, Inc.
|
-6.15 USD
|
87.317%
|
|
Chimerix, Inc.
|
-0.93 USD
|
16.129%
|
|
Corbus Pharmaceuticals Holdings, Inc.
|
-10.31 USD
|
92.435%
|
|
CRISPR Therapeutics AG
|
-1.94 USD
|
59.794%
|
|
Clearside Biomedical, Inc.
|
-0.53 USD
|
-47.17%
|
|
Precision BioSciences, Inc.
|
-15.96 USD
|
95.113%
|
|
Dyadic International, Inc.
|
-0.24 USD
|
-225.0%
|
|
Elevation Oncology, Inc.
|
-1.34 USD
|
41.791%
|
|
Fortress Biotech, Inc.
|
-8.47 USD
|
90.791%
|
|
GT Biopharma, Inc.
|
-5.64 USD
|
86.17%
|
|
Alkermes plc
|
2.14 USD
|
136.449%
|
|
Immix Biopharma, Inc.
|
-0.89 USD
|
12.36%
|
|
Innoviva, Inc.
|
2.92 USD
|
126.712%
|
|
IO Biotech, Inc.
|
-1.98 USD
|
60.606%
|
|
Jaguar Health, Inc.
|
-107.42 USD
|
99.274%
|
|
Ligand Pharmaceuticals Incorporated
|
3.02 USD
|
125.828%
|
|
ContextLogic Inc.
|
-13.36 USD
|
94.162%
|
|
AbCellera Biologics Inc.
|
-0.51 USD
|
-52.941%
|
|
Lantern Pharma Inc.
|
-1.47 USD
|
46.939%
|
|
Kintara Therapeutics, Inc.
|
-3.23 USD
|
75.851%
|
|
Arrowhead Pharmaceuticals, Inc.
|
-1.91 USD
|
59.162%
|
|
Madrigal Pharmaceuticals, Inc.
|
-19.99 USD
|
96.098%
|
|
MEI Pharma, Inc.
|
2.67 USD
|
129.213%
|
|
Barinthus Biotherapeutics plc
|
-1.91 USD
|
59.162%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
37.6%
|
|
Marinus Pharmaceuticals, Inc.
|
-2.63 USD
|
70.342%
|
|
NextCure, Inc.
|
-2.25 USD
|
65.333%
|
|
HOOKIPA Pharma Inc.
|
-8.63 USD
|
90.962%
|
|
ChromaDex Corporation
|
-0.07 USD
|
-1083.612%
|
|
IDEAYA Biosciences, Inc.
|
-1.96 USD
|
60.204%
|
|
Incyte Corporation
|
2.67 USD
|
129.213%
|
|
Opthea Limited
|
-0.35 USD
|
-122.857%
|
|
MiMedx Group, Inc.
|
0.48 USD
|
262.5%
|
|
Outlook Therapeutics, Inc.
|
-4.72 USD
|
83.475%
|
|
Aadi Bioscience, Inc.
|
-2.44 USD
|
68.033%
|
|
Psyence Biomedical Ltd.
|
-7.85 USD
|
90.064%
|
|
Vaxcyte, Inc.
|
-4.14 USD
|
81.159%
|
|
PDS Biotechnology Corporation
|
-1.39 USD
|
43.885%
|
|
Pharming Group N.V.
|
-0.16 USD
|
-387.5%
|
|
Pieris Pharmaceuticals, Inc.
|
-21.80 USD
|
96.422%
|
|
Onconetix, Inc.
|
-2.19 USD
|
64.384%
|
|
Acelyrin, Inc.
|
-5.43 USD
|
85.635%
|
|
PureTech Health plc
|
-2.38 USD
|
67.227%
|
|
Pyxis Oncology, Inc.
|
-1.85 USD
|
57.838%
|
|
Avidity Biosciences, Inc.
|
-2.91 USD
|
73.196%
|
|
TransCode Therapeutics, Inc.
|
-103.61 USD
|
99.247%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
37.6%
|
|
ESSA Pharma Inc.
|
-0.60 USD
|
-30.0%
|
|
Rigel Pharmaceuticals, Inc.
|
-1.44 USD
|
45.833%
|
|
Ocuphire Pharma, Inc.
|
-0.46 USD
|
-69.565%
|
|
Seer, Inc.
|
-1.35 USD
|
42.222%
|
|
Sangamo Therapeutics, Inc.
|
-1.48 USD
|
47.297%
|
|
SELLAS Life Sciences Group, Inc.
|
-1.34 USD
|
41.791%
|
|
Sol-Gel Technologies Ltd.
|
-1.01 USD
|
22.772%
|
|
Salarius Pharmaceuticals, Inc.
|
-0.00 USD
|
-20426.316%
|
|
Summit Therapeutics Inc.
|
-0.99 USD
|
21.212%
|
|
Sensei Biotherapeutics, Inc.
|
-1.22 USD
|
36.066%
|
|
Senti Biosciences, Inc.
|
-16.01 USD
|
95.128%
|
|
ImmuCell Corporation
|
-0.75 USD
|
-4.0%
|
|
Syros Pharmaceuticals, Inc.
|
-5.81 USD
|
86.575%
|
|
Janux Therapeutics, Inc.
|
-1.32 USD
|
40.909%
|
|
Precigen, Inc.
|
-0.39 USD
|
-100.0%
|
|
Longboard Pharmaceuticals, Inc.
|
-2.39 USD
|
67.364%
|
|
Oncternal Therapeutics, Inc.
|
-13.43 USD
|
94.192%
|
|
Stoke Therapeutics, Inc.
|
-2.38 USD
|
67.227%
|
|
Xeris Biopharma Holdings, Inc.
|
-0.45 USD
|
-73.333%
|
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-0.44 USD
|
-77.273%
|
|
Sorrento Therapeutics, Inc.
|
-1.37 USD
|
43.066%
|
|
Verrica Pharmaceuticals Inc.
|
-1.48 USD
|
47.297%
|
|
VistaGen Therapeutics, Inc.
|
-1.52 USD
|
48.684%
|
|
VYNE Therapeutics Inc.
|
-2.77 USD
|
71.841%
|
|
Windtree Therapeutics, Inc.
|
-92.23 USD
|
99.154%
|
|
Wave Life Sciences Ltd.
|
-0.54 USD
|
-44.444%
|
|
Fate Therapeutics, Inc.
|
-1.64 USD
|
52.439%
|
|
TRACON Pharmaceuticals, Inc.
|
-2.20 USD
|
64.545%
|
|
Inhibrx Biosciences, Inc.
|
-5.12 USD
|
84.766%
|
|
Catalyst Pharmaceuticals, Inc.
|
0.67 USD
|
216.418%
|
|
Orchestra BioMed Holdings, Inc.
|
-1.48 USD
|
47.297%
|
|
Alzamend Neuro, Inc.
|
-14.72 USD
|
94.701%
|
|
Rocket Pharmaceuticals, Inc.
|
-2.92 USD
|
73.288%
|
|
Aptose Biosciences Inc.
|
-7.58 USD
|
89.71%
|
|
ZyVersa Therapeutics, Inc.
|
-1089.67 USD
|
99.928%
|
|
Soligenix, Inc.
|
-12.66 USD
|
93.839%
|
|
Century Therapeutics, Inc.
|
-2.30 USD
|
66.087%
|
|
Kura Oncology, Inc.
|
-2.08 USD
|
62.5%
|
|
TScan Therapeutics, Inc.
|
-1.36 USD
|
42.647%
|
|
Intensity Therapeutics, Inc.
|
-1.38 USD
|
43.478%
|
|
Ocean Biomedical, Inc.
|
-0.03 USD
|
-2865.779%
|
|
CytomX Therapeutics, Inc.
|
-0.01 USD
|
-10029.87%
|
|
Autolus Therapeutics plc
|
-1.20 USD
|
35.0%
|
|
Mineralys Therapeutics, Inc.
|
-1.99 USD
|
60.804%
|
|
EyePoint Pharmaceuticals, Inc.
|
-1.82 USD
|
57.143%
|
|
Eterna Therapeutics Inc.
|
-4.08 USD
|
80.882%
|
|
Adaptive Biotechnologies Corporation
|
-1.56 USD
|
50.0%
|
|
GRI Bio, Inc.
|
-28.25 USD
|
97.239%
|
|
Xenetic Biosciences, Inc.
|
-2.71 USD
|
71.218%
|
|
Tenaya Therapeutics, Inc.
|
-1.68 USD
|
53.571%
|
|
IGM Biosciences, Inc.
|
-4.71 USD
|
83.439%
|
|
INmune Bio, Inc.
|
-1.67 USD
|
53.293%
|
|
Heron Therapeutics, Inc.
|
-0.80 USD
|
2.5%
|
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
89.791%
|
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
93.834%
|
|
Entero Therapeutics, Inc.
|
-47.88 USD
|
98.371%
|
|
Milestone Pharmaceuticals Inc.
|
-1.39 USD
|
43.885%
|
|
X4 Pharmaceuticals, Inc.
|
-0.57 USD
|
-36.842%
|
|
Atara Biotherapeutics, Inc.
|
-65.18 USD
|
98.803%
|
|
Coherus BioSciences, Inc.
|
-2.53 USD
|
69.17%
|
|
Verastem, Inc.
|
-3.96 USD
|
80.303%
|
|
Abeona Therapeutics Inc.
|
-2.53 USD
|
69.17%
|
|
Pliant Therapeutics, Inc.
|
-2.75 USD
|
71.636%
|
|
Tonix Pharmaceuticals Holding Corp.
|
-219.09 USD
|
99.644%
|
|
Histogen Inc.
|
-3.46 USD
|
77.457%
|
|
Aprea Therapeutics, Inc.
|
-3.95 USD
|
80.253%
|
|
Surrozen, Inc.
|
-21.33 USD
|
96.343%
|
|
Organovo Holdings, Inc.
|
-1.60 USD
|
51.25%
|
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
70.677%
|
|
Ovid Therapeutics Inc.
|
-0.74 USD
|
-5.405%
|
|
Panbela Therapeutics, Inc.
|
-232.42 Thousand USD
|
100.0%
|
|
CASI Pharmaceuticals, Inc.
|
-2.02 USD
|
61.386%
|
|
Cadrenal Therapeutics, Inc. Common Stock
|
-0.62 USD
|
-25.806%
|
|
Centessa Pharmaceuticals plc
|
-1.57 USD
|
50.318%
|
|
Hepion Pharmaceuticals, Inc.
|
-12.32 USD
|
93.669%
|
|
Arcturus Therapeutics Holdings Inc.
|
-1.12 USD
|
30.357%
|
|
BioRestorative Therapies, Inc.
|
-2.47 USD
|
68.421%
|
|
Apollomics, Inc.
|
-2.32 USD
|
66.379%
|
|
Amarin Corporation plc
|
-0.15 USD
|
-420.0%
|
|
Mesoblast Limited
|
-0.89 USD
|
12.36%
|
|
Turnstone Biologics Corp.
|
-4.77 USD
|
83.648%
|
|
Kymera Therapeutics, Inc.
|
-2.52 USD
|
69.048%
|
|
Synaptogenix, Inc.
|
-29.56 USD
|
97.361%
|
|
Tiziana Life Sciences Ltd
|
-0.16 USD
|
-387.5%
|
|
Aurinia Pharmaceuticals Inc.
|
-0.54 USD
|
-44.444%
|
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-168.966%
|
|
Monopar Therapeutics Inc.
|
-0.58 USD
|
-34.483%
|
|
Exelixis, Inc.
|
0.65 USD
|
220.0%
|
|
Better Therapeutics, Inc.
|
-1.69 USD
|
53.846%
|
|
Nurix Therapeutics, Inc.
|
-2.65 USD
|
70.566%
|
|
Apellis Pharmaceuticals, Inc.
|
-4.45 USD
|
82.472%
|
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-143.75%
|
|
Dermata Therapeutics, Inc.
|
-40.18 USD
|
98.059%
|
|
Aridis Pharmaceuticals, Inc.
|
-1.64 USD
|
52.439%
|
|
Gritstone bio, Inc.
|
-1.20 USD
|
35.0%
|
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
87.379%
|
|
TNF Pharmaceuticals, Inc.
|
-5.33 USD
|
85.366%
|
|
Avid Bioservices, Inc.
|
-2.23 USD
|
65.022%
|
|
Insmed Incorporated
|
-5.34 USD
|
85.393%
|
|
Virpax Pharmaceuticals, Inc.
|
-12.97 USD
|
93.986%
|
|
MediWound Ltd.
|
-0.75 USD
|
-4.0%
|
|
OmniAb, Inc.
|
-0.51 USD
|
-52.941%
|
|
Alector, Inc.
|
-1.56 USD
|
50.0%
|
|
Seres Therapeutics, Inc.
|
-0.89 USD
|
12.36%
|
|
Checkpoint Therapeutics, Inc.
|
-2.77 USD
|
71.841%
|
|
Zai Lab Limited
|
-3.46 USD
|
77.457%
|
|
Revance Therapeutics, Inc.
|
-3.83 USD
|
79.634%
|
|
Aura Biosciences, Inc.
|
-1.93 USD
|
59.585%
|
|
Lyell Immunopharma, Inc.
|
-0.93 USD
|
16.129%
|
|
Immunic, Inc.
|
-2.11 USD
|
63.033%
|
|
Tarsus Pharmaceuticals, Inc.
|
-4.62 USD
|
83.117%
|
|
Veracyte, Inc.
|
-1.02 USD
|
23.529%
|
|
InMed Pharmaceuticals Inc.
|
-1.01 USD
|
22.772%
|
|
FibroGen, Inc.
|
-2.92 USD
|
73.288%
|
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
97.425%
|
|
Adial Pharmaceuticals, Inc.
|
-5.44 USD
|
85.662%
|
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.14 USD
|
95.7%
|
|
Jazz Pharmaceuticals plc
|
6.95 USD
|
111.223%
|
|
Cyclacel Pharmaceuticals, Inc.
|
-26.75 USD
|
97.084%
|
|
Amylyx Pharmaceuticals, Inc.
|
0.73 USD
|
206.849%
|
|
TG Therapeutics, Inc.
|
0.09 USD
|
973.46%
|
|
Galecto, Inc.
|
-36.08 USD
|
97.838%
|
|
Calithera Biosciences, Inc.
|
-7.94 USD
|
90.176%
|
|
Fortrea Holdings Inc.
|
-0.04 USD
|
-1936.554%
|
|
KalVista Pharmaceuticals, Inc.
|
-3.44 USD
|
77.326%
|
|
Aptevo Therapeutics Inc.
|
-62.62 USD
|
98.754%
|
|
XBiotech Inc.
|
-0.81 USD
|
3.704%
|
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
87.379%
|
|
Lyra Therapeutics, Inc.
|
-1.26 USD
|
38.095%
|
|
Foghorn Therapeutics Inc.
|
-2.34 USD
|
66.667%
|
|
Y-mAbs Therapeutics, Inc.
|
-0.49 USD
|
-59.184%
|
|
Theravance Biopharma, Inc.
|
-1.00 USD
|
22.0%
|
|
Ultragenyx Pharmaceutical Inc.
|
-8.25 USD
|
90.545%
|
|
Metagenomi, Inc. Common Stock
|
-1.82 USD
|
57.143%
|
|
Vaxxinity, Inc.
|
-0.45 USD
|
-73.333%
|
|
BioCryst Pharmaceuticals, Inc.
|
-1.18 USD
|
33.898%
|
|
Gain Therapeutics, Inc.
|
-1.71 USD
|
54.386%
|
|
Cartesian Therapeutics, Inc.
|
-42.49 USD
|
98.164%
|
|
NexImmune, Inc.
|
-30.82 USD
|
97.469%
|
|
Creative Medical Technology Holdings, Inc.
|
-3.76 USD
|
79.255%
|
|
Marker Therapeutics, Inc.
|
-1.93 USD
|
59.585%
|
|
Regeneron Pharmaceuticals, Inc.
|
37.05 USD
|
102.105%
|
|
Chemomab Therapeutics Ltd.
|
-2.06 USD
|
62.136%
|
|
Scopus BioPharma Inc.
|
-0.55 USD
|
-41.818%
|
|
RAPT Therapeutics, Inc.
|
-3.05 USD
|
74.426%
|
|
Ainos, Inc.
|
-3.36 USD
|
76.786%
|
|
Pluri Inc.
|
-3.99 USD
|
80.451%
|
|
Prothena Corporation plc
|
-2.76 USD
|
71.739%
|
|
Adaptimmune Therapeutics plc
|
-0.57 USD
|
-36.842%
|
|
Celularity Inc.
|
-11.02 USD
|
92.922%
|
|
Rallybio Corporation
|
-1.84 USD
|
57.609%
|
|
Cue Biopharma, Inc.
|
-1.11 USD
|
29.73%
|
|
MeiraGTx Holdings plc
|
-1.49 USD
|
47.651%
|
|
Omeros Corporation
|
-1.88 USD
|
58.511%
|
|
Humacyte, Inc.
|
-1.07 USD
|
27.103%
|
|
Immunocore Holdings plc
|
-1.13 USD
|
30.973%
|
|
Cocrystal Pharma, Inc.
|
-1.86 USD
|
58.065%
|
|
Cidara Therapeutics, Inc.
|
-5.25 USD
|
85.143%
|
|
Blueprint Medicines Corporation
|
-8.37 USD
|
90.681%
|
|
CalciMedica, Inc.
|
-7.65 USD
|
89.804%
|
|
Cabaletta Bio, Inc.
|
-1.65 USD
|
52.727%
|
|
Scholar Rock Holding Corporation
|
-1.99 USD
|
60.804%
|
|
Sana Biotechnology, Inc.
|
-1.46 USD
|
46.575%
|
|
Pulmatrix, Inc.
|
-3.87 USD
|
79.845%
|
|
Elicio Therapeutics, Inc.
|
-6.96 USD
|
88.793%
|
|
Vigil Neuroscience, Inc.
|
-2.13 USD
|
63.38%
|
|
Intellia Therapeutics, Inc.
|
-5.42 USD
|
85.609%
|
|
Adlai Nortye Ltd. American Depositary Shares
|
-7.26 USD
|
89.256%
|
|
Cytokinetics, Incorporated
|
-5.45 USD
|
85.688%
|
|
Eloxx Pharmaceuticals, Inc.
|
-16.65 USD
|
95.315%
|
|
Nutriband Inc.
|
-0.69 USD
|
-13.043%
|
|
Protara Therapeutics, Inc.
|
-3.57 USD
|
78.151%
|
|
Vor Biopharma Inc.
|
-1.75 USD
|
55.429%
|
|
Roivant Sciences Ltd.
|
5.55 USD
|
114.054%
|
|
Evogene Ltd.
|
-5.23 USD
|
85.086%
|
|
ProKidney Corp.
|
-0.57 USD
|
-36.842%
|
|
Applied Therapeutics, Inc.
|
-1.42 USD
|
45.07%
|
|
Hoth Therapeutics, Inc.
|
-2.30 USD
|
66.087%
|
|
BridgeBio Pharma, Inc.
|
-3.95 USD
|
80.253%
|
|
CorMedix Inc.
|
-0.91 USD
|
14.286%
|
|
BioLineRx Ltd.
|
-0.94 USD
|
17.021%
|
|
Tango Therapeutics, Inc.
|
-1.08 USD
|
27.778%
|
|
Galectin Therapeutics Inc.
|
-0.74 USD
|
-5.405%
|
|
Atai Life Sciences N.V.
|
-0.25 USD
|
-212.0%
|
|
Renovaro Biosciences Inc.
|
-0.84 USD
|
7.143%
|
|
Aerovate Therapeutics, Inc.
|
-2.87 USD
|
72.822%
|
|
Zentalis Pharmaceuticals, Inc.
|
-4.47 USD
|
82.55%
|
|
Sagimet Biosciences Inc.
|
-2.66 USD
|
70.677%
|
|
MediciNova, Inc.
|
-0.17 USD
|
-358.824%
|
|
Praxis Precision Medicines, Inc.
|
-18.69 USD
|
95.827%
|
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
-18.182%
|
|
GeoVax Labs, Inc.
|
-10.22 USD
|
92.368%
|
|
Axsome Therapeutics, Inc.
|
-5.27 USD
|
85.199%
|
|
Biomea Fusion, Inc.
|
-3.44 USD
|
77.326%
|
|
PTC Therapeutics, Inc.
|
-8.37 USD
|
90.681%
|
|
Mereo BioPharma Group plc
|
-0.04 USD
|
-1644.966%
|
|
Cullinan Oncology, Inc.
|
-3.69 USD
|
78.862%
|
|
Syndax Pharmaceuticals, Inc.
|
-2.98 USD
|
73.826%
|
|
Absci Corporation
|
-1.20 USD
|
35.0%
|
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
80.402%
|
|
4D Molecular Therapeutics, Inc.
|
-2.58 USD
|
69.767%
|
|
Dyne Therapeutics, Inc.
|
-3.95 USD
|
80.253%
|
|
Kiniksa Pharmaceuticals, Ltd.
|
0.20 USD
|
490.0%
|
|
Ventyx Biosciences, Inc.
|
-3.30 USD
|
76.364%
|
|
Allakos Inc.
|
-2.14 USD
|
63.551%
|
|
Imunon, Inc.
|
-2.16 USD
|
63.889%
|
|
Fulcrum Therapeutics, Inc.
|
-1.59 USD
|
50.943%
|
|
Corcept Therapeutics Incorporated
|
1.02 USD
|
176.471%
|
|
BioAtla, Inc.
|
-2.58 USD
|
69.767%
|
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-143.75%
|
|
Bio-Path Holdings, Inc.
|
-33.64 USD
|
97.681%
|
|
Allogene Therapeutics, Inc.
|
-2.09 USD
|
62.679%
|
|
Larimar Therapeutics, Inc.
|
-0.84 USD
|
7.143%
|
|
XOMA Corporation
|
-4.04 USD
|
80.693%
|
|
Kezar Life Sciences, Inc.
|
-1.40 USD
|
44.286%
|
|
Cara Therapeutics, Inc.
|
-2.19 USD
|
64.384%
|
|
aTyr Pharma, Inc.
|
-0.94 USD
|
17.021%
|
|
Aligos Therapeutics, Inc.
|
-3.52 USD
|
77.841%
|
|
Akero Therapeutics, Inc.
|
-2.89 USD
|
73.01%
|
|
Viridian Therapeutics, Inc.
|
-5.31 USD
|
85.311%
|
|
Eliem Therapeutics, Inc.
|
-1.30 USD
|
40.0%
|
|
EyeGate Pharmaceuticals, Inc.
|
-2.54 USD
|
69.291%
|
|
Akari Therapeutics, Plc
|
-2.04 USD
|
61.765%
|
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-194900.0%
|
|
Halozyme Therapeutics, Inc.
|
2.13 USD
|
136.62%
|
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
22.772%
|
|
UroGen Pharma Ltd.
|
-3.55 USD
|
78.028%
|
|
Sutro Biopharma, Inc.
|
-1.78 USD
|
56.18%
|
|
ZIVO Bioscience, Inc.
|
-4.60 USD
|
83.043%
|
|
Orgenesis Inc.
|
-1.91 USD
|
59.162%
|
|
Entera Bio Ltd.
|
-0.31 USD
|
-151.613%
|
|
GH Research PLC
|
-0.68 USD
|
-14.706%
|
|
Lisata Therapeutics, Inc.
|
-2.58 USD
|
69.767%
|
|
Reneo Pharmaceuticals, Inc.
|
-25.23 USD
|
96.908%
|
|
Xencor, Inc.
|
-2.08 USD
|
62.5%
|
|
60 Degrees Pharmaceuticals, Inc.
|
-0.95 USD
|
17.895%
|
|
Replimune Group, Inc.
|
-3.24 USD
|
75.926%
|
|
Coeptis Therapeutics Holdings, Inc.
|
-0.83 USD
|
6.024%
|
|
Vanda Pharmaceuticals Inc.
|
0.04 USD
|
1884.897%
|
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
22.772%
|
|
Portage Biotech Inc.
|
-3.70 USD
|
78.919%
|
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
-18.182%
|
|
Olema Pharmaceuticals, Inc.
|
-2.14 USD
|
63.551%
|
|
OncoCyte Corporation
|
-3.75 USD
|
79.2%
|
|
Qualigen Therapeutics, Inc.
|
-2.46 USD
|
68.293%
|
|
Processa Pharmaceuticals, Inc.
|
-8.48 USD
|
90.802%
|
|
Purple Biotech Ltd.
|
-0.09 USD
|
-768.597%
|
|
CollPlant Biotechnologies Ltd.
|
-0.62 USD
|
-25.806%
|
|
scPharmaceuticals Inc.
|
-1.42 USD
|
45.07%
|
|
ProMIS Neurosciences, Inc.
|
-1.42 USD
|
45.07%
|
|
HilleVax, Inc.
|
-3.04 USD
|
74.342%
|
|
NeuroSense Therapeutics Ltd.
|
-0.83 USD
|
6.024%
|
|
Tharimmune, Inc.
|
-107.08 USD
|
99.272%
|
|
Genprex, Inc.
|
-22.58 USD
|
96.546%
|
|
Neumora Therapeutics, Inc. Common Stock
|
-1.49 USD
|
47.651%
|
|
Atossa Therapeutics, Inc.
|
-0.24 USD
|
-225.0%
|
|
XTL Biopharmaceuticals Ltd.
|
-0.00 USD
|
-23536.364%
|
|
Virios Therapeutics, Inc.
|
-0.28 USD
|
-178.571%
|
|
OKYO Pharma Limited
|
-0.00 USD
|
-129900.0%
|
|
Savara Inc.
|
-0.33 USD
|
-136.364%
|
|
Curis, Inc.
|
-8.96 USD
|
91.295%
|
|
Daré Bioscience, Inc.
|
-4.15 USD
|
81.205%
|
|
Carmell Therapeutics Corporation
|
-1.46 USD
|
46.575%
|
|
Titan Pharmaceuticals, Inc.
|
-7.41 USD
|
89.474%
|
|
Achieve Life Sciences, Inc.
|
-1.50 USD
|
48.0%
|
|
BeiGene, Ltd.
|
-8.45 USD
|
90.769%
|
|
Kiromic BioPharma, Inc.
|
-21.41 USD
|
96.357%
|
|
Revolution Medicines, Inc. Warrant
|
-3.86 USD
|
79.793%
|
|
Protagonist Therapeutics, Inc.
|
-1.39 USD
|
43.885%
|
|
Erasca, Inc.
|
-0.83 USD
|
6.024%
|
|
bluebird bio, Inc.
|
-1.93 USD
|
59.585%
|
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
32.174%
|
|
BioMarin Pharmaceutical Inc.
|
0.89 USD
|
187.64%
|
|
DBV Technologies S.A.
|
-0.76 USD
|
-2.632%
|
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
32.174%
|
|
Moderna, Inc.
|
-12.34 USD
|
93.679%
|
|
Vincerx Pharma, Inc.
|
-1.89 USD
|
58.73%
|
|
Fresh Tracks Therapeutics, Inc.
|
-0.96 USD
|
18.75%
|
|
Molecular Templates, Inc.
|
-1.80 USD
|
56.667%
|
|
Acrivon Therapeutics, Inc. Common Stock
|
-2.74 USD
|
71.533%
|
|
Travere Therapeutics, Inc.
|
-1.50 USD
|
48.0%
|
|
Monte Rosa Therapeutics, Inc.
|
-2.63 USD
|
70.342%
|
|
Spruce Biosciences, Inc.
|
-1.24 USD
|
37.097%
|
|
Celldex Therapeutics, Inc.
|
-2.92 USD
|
73.288%
|
|
Cogent Biosciences, Inc.
|
-2.42 USD
|
67.769%
|
|
MacroGenics, Inc.
|
-0.15 USD
|
-420.0%
|
|
RenovoRx, Inc.
|
-0.99 USD
|
21.212%
|
|
Adicet Bio, Inc.
|
-3.31 USD
|
76.435%
|
|
Prime Medicine, Inc.
|
-2.18 USD
|
64.22%
|
|
Aditxt, Inc.
|
-4326.64 USD
|
99.982%
|
|
Adagene Inc.
|
-0.44 USD
|
-77.273%
|
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-271.429%
|
|
Quantum-Si incorporated
|
-0.68 USD
|
-14.706%
|
|
Maravai LifeSciences Holdings, Inc.
|
-0.90 USD
|
13.333%
|
|
Acurx Pharmaceuticals, Inc.
|
-1.15 USD
|
32.174%
|
|
Voyager Therapeutics, Inc.
|
3.08 USD
|
125.325%
|
|
SciSparc Ltd.
|
-14.43 USD
|
94.595%
|
|
Vericel Corporation
|
-0.07 USD
|
-1065.919%
|
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-47.17%
|
|
Minerva Neurosciences, Inc.
|
-4.61 USD
|
83.08%
|
|
Generation Bio Co.
|
-1.96 USD
|
60.204%
|
|
Astria Therapeutics, Inc.
|
-2.42 USD
|
67.769%
|
|
Black Diamond Therapeutics, Inc.
|
-1.88 USD
|
58.511%
|
|
Arcutis Biotherapeutics, Inc.
|
-3.78 USD
|
79.365%
|
|
Invivyd, Inc.
|
-1.81 USD
|
56.906%
|
|
Relay Therapeutics, Inc.
|
-2.79 USD
|
72.043%
|
|
Quoin Pharmaceuticals, Ltd.
|
-9.64 USD
|
91.909%
|
|
Spero Therapeutics, Inc.
|
0.43 USD
|
281.395%
|
|
Artelo Biosciences, Inc.
|
-3.49 USD
|
77.65%
|
|
2seventy bio, Inc.
|
-4.42 USD
|
82.353%
|
|
ADMA Biologics, Inc.
|
-0.13 USD
|
-500.0%
|
|
Clene Inc.
|
-9.43 USD
|
91.729%
|
|
Capricor Therapeutics, Inc.
|
-0.83 USD
|
6.024%
|
|
Boundless Bio, Inc. Common Stock
|
-2.22 USD
|
64.865%
|
|
GeoVax Labs, Inc.
|
-10.22 USD
|
92.368%
|
|
Recursion Pharmaceuticals, Inc.
|
-1.58 USD
|
50.633%
|
|
Citius Pharmaceuticals, Inc.
|
-0.22 USD
|
-254.545%
|
|
Contineum Therapeutics, Inc. Class A Common Stock
|
1.36 USD
|
157.353%
|
|
Relmada Therapeutics, Inc.
|
-3.28 USD
|
76.22%
|
|
Finch Therapeutics Group, Inc.
|
-46.59 USD
|
98.326%
|
|
ALX Oncology Holdings Inc.
|
-3.74 USD
|
79.144%
|
|
Vir Biotechnology, Inc.
|
-4.59 USD
|
83.007%
|
|
Evaxion Biotech A/S
|
-8.11 USD
|
90.382%
|
|
Ocular Therapeutix, Inc.
|
-1.09 USD
|
28.44%
|
|
Verve Therapeutics, Inc.
|
-3.12 USD
|
75.0%
|
|
Trevena, Inc.
|
-54.51 USD
|
98.569%
|
|
Surrozen, Inc.
|
-21.33 USD
|
96.343%
|
|
Tyra Biosciences, Inc.
|
-1.62 USD
|
51.852%
|
|
Cingulate Inc.
|
-311.99 USD
|
99.75%
|
|
Galmed Pharmaceuticals Ltd.
|
-30.05 USD
|
97.404%
|
|
Unity Biotechnology, Inc.
|
-2.70 USD
|
71.111%
|
|
Tenax Therapeutics, Inc.
|
-31.09 USD
|
97.491%
|
|
Terns Pharmaceuticals, Inc.
|
-1.27 USD
|
38.583%
|
|
ACADIA Pharmaceuticals Inc.
|
-0.37 USD
|
-110.811%
|
|
Connect Biopharma Holdings Limited
|
-1.08 USD
|
27.778%
|
|
Clearmind Medicine Inc.
|
-59.18 USD
|
98.682%
|
|
Kronos Bio, Inc.
|
-1.95 USD
|
60.0%
|
|
Bolt Biotherapeutics, Inc.
|
-1.83 USD
|
57.377%
|
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-100.0%
|
|
Viking Therapeutics, Inc.
|
-0.91 USD
|
14.286%
|
|
Statera Biopharma, Inc.
|
-4.97 USD
|
84.306%
|
|
ImmunityBio, Inc.
|
-1.15 USD
|
32.174%
|
|
Korro Bio, Inc.
|
-53.08 USD
|
98.531%
|
|
Kineta, Inc.
|
-1.28 USD
|
39.063%
|
|
BioVie Inc.
|
-7.30 USD
|
89.315%
|
|
Codexis, Inc.
|
-1.12 USD
|
30.357%
|
|
Celularity Inc.
|
-11.02 USD
|
92.922%
|
|
Crinetics Pharmaceuticals, Inc.
|
-3.69 USD
|
78.862%
|
|
Celcuity Inc.
|
-2.69 USD
|
71.004%
|
|
Virax Biolabs Group Limited
|
-3.36 USD
|
76.786%
|
|
Cibus, Inc.
|
-25.95 USD
|
96.994%
|
|
Eledon Pharmaceuticals, Inc.
|
-0.00 USD
|
-48650.0%
|
|
eFFECTOR Therapeutics, Inc.
|
-16.37 USD
|
95.235%
|
|
IN8bio, Inc.
|
-1.00 USD
|
22.0%
|
|
Kodiak Sciences Inc.
|
-4.97 USD
|
84.306%
|
|
Annexon, Inc.
|
-1.77 USD
|
55.932%
|
|
Adverum Biotechnologies, Inc.
|
-11.62 USD
|
93.287%
|
|
Assembly Biosciences, Inc.
|
-13.38 USD
|
94.17%
|
|
Avalo Therapeutics, Inc.
|
-113.58 USD
|
99.313%
|
|
Ionis Pharmaceuticals, Inc.
|
-2.56 USD
|
69.531%
|
|
Eyenovia, Inc.
|
-0.66 USD
|
-18.182%
|
|
Puma Biotechnology, Inc.
|
0.46 USD
|
269.565%
|
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-762.832%
|
|
Xilio Therapeutics, Inc.
|
-2.78 USD
|
71.942%
|
|
Arcellx, Inc.
|
-1.47 USD
|
46.939%
|
|
Cardiff Oncology, Inc.
|
-0.93 USD
|
16.129%
|
|
Enanta Pharmaceuticals, Inc.
|
-6.38 USD
|
87.774%
|
|
Regulus Therapeutics Inc.
|
-1.58 USD
|
50.633%
|
|
Moolec Science SA
|
-1.50 USD
|
48.0%
|
|
Acumen Pharmaceuticals, Inc.
|
-1.08 USD
|
27.778%
|
|
Geron Corporation
|
-0.32 USD
|
-143.75%
|
|
LAVA Therapeutics N.V.
|
-1.57 USD
|
50.318%
|
|
Royalty Pharma plc
|
3.41 USD
|
122.874%
|
|
Atea Pharmaceuticals, Inc.
|
-1.63 USD
|
52.147%
|
|
Greenwich LifeSciences, Inc.
|
-0.69 USD
|
-13.043%
|
|
TFF Pharmaceuticals, Inc.
|
-11.85 USD
|
93.418%
|
|
Mersana Therapeutics, Inc.
|
-1.48 USD
|
47.297%
|
|
Humacyte, Inc.
|
-1.07 USD
|
27.103%
|
|
Structure Therapeutics Inc.
|
-2.44 USD
|
68.033%
|
|
89bio, Inc.
|
-2.00 USD
|
61.0%
|
|
PMV Pharmaceuticals, Inc.
|
-1.44 USD
|
45.833%
|
|
Avenue Therapeutics, Inc.
|
-73.60 USD
|
98.94%
|
|
Genelux Corporation
|
-1.16 USD
|
32.759%
|
|
Trevi Therapeutics, Inc.
|
-0.29 USD
|
-168.966%
|
|
Lexicon Pharmaceuticals, Inc.
|
-0.80 USD
|
2.5%
|
|
Notable Labs, Ltd.
|
-5.03 USD
|
84.493%
|
|
Liquidia Corporation
|
-1.21 USD
|
35.537%
|
|
Mustang Bio, Inc.
|
-6.00 USD
|
87.0%
|
|
Immunovant, Inc.
|
-1.88 USD
|
58.511%
|
|
Quantum-Si incorporated
|
-0.68 USD
|
-14.706%
|
|
Arbutus Biopharma Corporation
|
-0.44 USD
|
-77.273%
|
|
DiaMedica Therapeutics Inc.
|
-0.60 USD
|
-30.0%
|
|
Vera Therapeutics, Inc.
|
-2.25 USD
|
65.333%
|
|
Acasti Pharma Inc.
|
-1.35 USD
|
42.222%
|
|
MiNK Therapeutics, Inc.
|
-0.65 USD
|
-20.0%
|
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
93.834%
|
|
Xenon Pharmaceuticals Inc.
|
-2.73 USD
|
71.429%
|
|
Elevai Labs, Inc. Common Stock
|
-0.40 USD
|
-95.0%
|
|
NeuroBo Pharmaceuticals, Inc.
|
-2.46 USD
|
68.293%
|
|
Tempest Therapeutics, Inc.
|
-1.91 USD
|
59.162%
|
|
Soleno Therapeutics, Inc.
|
-2.36 USD
|
66.949%
|
|
PepGen Inc.
|
-3.30 USD
|
76.364%
|
|
Moleculin Biotech, Inc.
|
-15.07 USD
|
94.824%
|
|
United Therapeutics Corporation
|
21.04 USD
|
103.707%
|
|
Nuvectis Pharma, Inc.
|
-1.43 USD
|
45.455%
|
|
Solid Biosciences Inc.
|
-4.83 USD
|
83.851%
|
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-168.966%
|
|
Immuneering Corporation
|
-1.88 USD
|
58.511%
|
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
70.677%
|
|
Silo Pharma, Inc.
|
-1.20 USD
|
35.0%
|
|
Belite Bio, Inc
|
-1.19 USD
|
34.454%
|
|
XOMA Corporation
|
-4.04 USD
|
80.693%
|
|
ARS Pharmaceuticals, Inc.
|
-0.57 USD
|
-36.842%
|
|
Bionomics Limited
|
-1.02 USD
|
23.529%
|
|
Apogee Therapeutics, Inc.
|
-0.00 USD
|
-22841.176%
|
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-85.714%
|
|
uniQure N.V.
|
-6.47 USD
|
87.944%
|
|
Cassava Sciences, Inc.
|
-2.32 USD
|
66.379%
|
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-271.429%
|
|
Poseida Therapeutics, Inc.
|
-1.37 USD
|
43.066%
|
|
Forte Biosciences, Inc.
|
-24.92 USD
|
96.87%
|
|
Anebulo Pharmaceuticals, Inc.
|
-0.32 USD
|
-143.75%
|
|
Enlivex Therapeutics Ltd.
|
-1.56 USD
|
50.0%
|
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-762.832%
|
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
97.425%
|
|
FibroBiologics, Inc. Common Stock
|
-0.59 USD
|
-32.203%
|
|
Altimmune, Inc.
|
-1.66 USD
|
53.012%
|
|
Amicus Therapeutics, Inc.
|
-0.51 USD
|
-52.941%
|
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-85.714%
|
|
Compugen Ltd.
|
-0.21 USD
|
-271.429%
|
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
|
Zevra Therapeutics, Inc.
|
-1.30 USD
|
40.0%
|
|
Benitec Biopharma Inc.
|
-5.36 USD
|
85.448%
|
|
Spyre Therapeutics, Inc.
|
-49.12 USD
|
98.412%
|
|
NKGen Biotech, Inc. Common Stock
|
-5.38 USD
|
85.502%
|
|
Zura Bio Limited
|
-2.09 USD
|
62.679%
|
|
PolyPid Ltd.
|
-16.99 USD
|
95.409%
|
|
Aileron Therapeutics, Inc.
|
-3.42 USD
|
77.193%
|
|
NKGen Biotech, Inc. Warrants
|
-5.38 USD
|
85.502%
|
|
Instil Bio, Inc.
|
-24.00 USD
|
96.75%
|
|
argenx SE
|
-5.16 USD
|
84.884%
|
|
Immunome, Inc.
|
-5.38 USD
|
85.502%
|
|
Compass Therapeutics, Inc.
|
-0.33 USD
|
-136.364%
|
|
Verona Pharma plc
|
-0.54 USD
|
-44.444%
|
|
enGene Holdings Inc. Warrants
|
-4.51 USD
|
82.705%
|
|
Shattuck Labs, Inc.
|
-2.05 USD
|
61.951%
|
|
CervoMed Inc.
|
-0.82 USD
|
4.878%
|
|
LENZ Therapeutics, Inc.
|
-15.30 USD
|
94.902%
|
|
Plus Therapeutics, Inc.
|
-4.24 USD
|
81.604%
|
|
Dianthus Therapeutics, Inc.
|
-8.45 USD
|
90.769%
|
|
Moolec Science SA
|
-1.50 USD
|
48.0%
|
|
Enveric Biosciences, Inc.
|
-8.09 USD
|
90.358%
|
|
Inovio Pharmaceuticals, Inc.
|
-6.09 USD
|
87.192%
|
|
AnaptysBio, Inc.
|
-6.08 USD
|
87.171%
|
|
Design Therapeutics, Inc.
|
-1.19 USD
|
34.454%
|
|
Leap Therapeutics, Inc.
|
-3.98 USD
|
80.402%
|
|
NeurAxis, Inc.
|
-4.03 USD
|
80.645%
|
|
Seelos Therapeutics, Inc.
|
-7.73 USD
|
89.909%
|
|
Lumos Pharma, Inc.
|
-4.18 USD
|
81.34%
|
|
Achilles Therapeutics plc
|
-1.74 USD
|
55.172%
|
|
enGene Holdings Inc. Common Stock
|
-4.51 USD
|
82.705%
|
|
180 Life Sciences Corp.
|
-52.60 USD
|
98.517%
|
|
Opiant Pharmaceuticals, Inc.
|
0.68 USD
|
214.706%
|
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-100.0%
|
|
Nutriband Inc.
|
-0.69 USD
|
-13.043%
|
|
ORIC Pharmaceuticals, Inc.
|
-1.96 USD
|
60.204%
|
|
CG Oncology, Inc. Common stock
|
-15.65 USD
|
95.016%
|
|
Fractyl Health, Inc. Common Stock
|
-1.98 USD
|
60.606%
|
|
Rani Therapeutics Holdings, Inc.
|
-1.33 USD
|
41.353%
|
|
MoonLake Immunotherapeutics
|
-0.73 USD
|
-6.849%
|
|
Palisade Bio, Inc.
|
-27.01 USD
|
97.112%
|
|
Tourmaline Bio, Inc.
|
-8.87 USD
|
91.206%
|
|
Beam Therapeutics Inc.
|
-1.72 USD
|
54.651%
|
|
Neurogene Inc.
|
-2.83 USD
|
72.438%
|
|
Mirum Pharmaceuticals, Inc.
|
-4.00 USD
|
80.5%
|
|
AEON Biopharma, Inc.
|
- USD
|
Infinity%
|
|
Sesen Bio, Inc.
|
-1.99 USD
|
60.804%
|
|
Enliven Therapeutics, Inc.
|
-2.01 USD
|
61.194%
|
|
Kiora Pharmaceuticals, Inc.
|
-24.25 USD
|
96.784%
|
|
Iovance Biotherapeutics, Inc.
|
-1.89 USD
|
58.73%
|
|
Taysha Gene Therapies, Inc.
|
-0.96 USD
|
18.75%
|
|
Athira Pharma, Inc.
|
-3.10 USD
|
74.839%
|
|
Vaccinex, Inc.
|
-43.68 USD
|
98.214%
|
|
HCW Biologics Inc.
|
-0.70 USD
|
-11.429%
|
|
XOMA Corporation
|
-4.04 USD
|
80.693%
|
|
Nektar Therapeutics
|
-1.45 USD
|
46.207%
|
|
Arvinas, Inc.
|
-6.62 USD
|
88.218%
|
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-194900.0%
|
|
Merus N.V.
|
-3.00 USD
|
74.0%
|
|
Omega Therapeutics, Inc.
|
-1.80 USD
|
56.667%
|
|
Quince Therapeutics, Inc.
|
-0.84 USD
|
7.143%
|
|
Rezolute, Inc.
|
-1.33 USD
|
41.353%
|
|
Clene Inc.
|
-9.43 USD
|
91.729%
|
|
Indaptus Therapeutics, Inc.
|
-1.84 USD
|
57.609%
|
|
BeyondSpring Inc.
|
-0.54 USD
|
-44.444%
|
|
Synlogic, Inc.
|
-8.81 USD
|
91.146%
|
|
Allarity Therapeutics, Inc.
|
-0.01 USD
|
-7472.816%
|
|
Phio Pharmaceuticals Corp.
|
-46.87 USD
|
98.336%
|
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
|
Werewolf Therapeutics, Inc.
|
-1.05 USD
|
25.714%
|
|
Krystal Biotech, Inc.
|
0.40 USD
|
295.0%
|
|
Karyopharm Therapeutics Inc.
|
-1.25 USD
|
37.6%
|
|
SpringWorks Therapeutics, Inc.
|
-5.15 USD
|
84.854%
|
|
Lipella Pharmaceuticals Inc.
|
-0.77 USD
|
-1.299%
|
|
MannKind Corporation
|
-0.04 USD
|
-1644.966%
|
|
Ikena Oncology, Inc.
|
-1.63 USD
|
52.147%
|
|
Cyclerion Therapeutics, Inc.
|
-8.99 USD
|
91.324%
|
|
Gyre Therapeutics, Inc.
|
-1.41 USD
|
44.681%
|
|
Gossamer Bio, Inc.
|
-1.18 USD
|
33.898%
|
|
CohBar, Inc.
|
-4.13 USD
|
81.114%
|
|
Cognition Therapeutics, Inc.
|
-0.86 USD
|
9.302%
|
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
80.402%
|
|
Legend Biotech Corporation
|
-2.94 USD
|
73.469%
|
|
Mural Oncology plc
|
-12.43 USD
|
93.725%
|
|
Biora Therapeutics, Inc.
|
-7.87 USD
|
90.089%
|
|
PaxMedica, Inc. Common Stock
|
-11.00 USD
|
92.909%
|
|
Disc Medicine, Inc.
|
-3.43 USD
|
77.259%
|
|
Champions Oncology, Inc.
|
-0.54 USD
|
-44.444%
|
|
REGENXBIO Inc.
|
-6.02 USD
|
87.043%
|
|
Ensysce Biosciences, Inc.
|
-4.69 USD
|
83.369%
|
|
Anavex Life Sciences Corp.
|
-0.60 USD
|
-30.0%
|
|
Cellectar Biosciences, Inc.
|
-3.11 USD
|
74.92%
|
|
Edgewise Therapeutics, Inc.
|
-1.57 USD
|
50.318%
|
|
Vaxart, Inc.
|
-0.57 USD
|
-36.842%
|
|
PharmaCyte Biotech, Inc.
|
-1.80 USD
|
56.667%
|
|
Aldeyra Therapeutics, Inc.
|
-0.64 USD
|
-21.875%
|
|
Cellectis S.A.
|
-1.77 USD
|
55.932%
|
|
Longeveron Inc.
|
-10.22 USD
|
92.368%
|
|
Repare Therapeutics Inc.
|
-2.23 USD
|
65.022%
|
|
Sarepta Therapeutics, Inc.
|
-5.80 USD
|
86.552%
|
|
Inozyme Pharma, Inc.
|
-1.37 USD
|
43.066%
|
|
Revolution Medicines, Inc.
|
-3.86 USD
|
79.793%
|
|
Nymox Pharmaceutical Corporation
|
-0.07 USD
|
-961.224%
|
|
ArriVent BioPharma, Inc. Common Stock
|
-2.17 USD
|
64.055%
|
|
AN2 Therapeutics, Inc.
|
-2.74 USD
|
71.533%
|
|
Anixa Biosciences, Inc.
|
-0.32 USD
|
-143.75%
|
|
Vertex Pharmaceuticals Incorporated
|
14.05 USD
|
105.552%
|
|
Denali Therapeutics Inc.
|
-1.06 USD
|
26.415%
|
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-47.17%
|
|
Veru Inc.
|
-1.10 USD
|
29.091%
|
|
Corvus Pharmaceuticals, Inc.
|
-0.56 USD
|
-39.286%
|
|
Cingulate Inc.
|
-311.99 USD
|
99.75%
|
|
Passage Bio, Inc.
|
-1.86 USD
|
58.065%
|
|
Context Therapeutics Inc.
|
-1.50 USD
|
48.0%
|
|
Exicure, Inc.
|
-2.11 USD
|
63.033%
|
|
Day One Biopharmaceuticals, Inc.
|
-2.37 USD
|
67.089%
|
|
Oramed Pharmaceuticals Inc.
|
-0.97 USD
|
19.588%
|
|
Scinai Immunotherapeutics Ltd.
|
-16.62 USD
|
95.307%
|
|
Rhythm Pharmaceuticals, Inc.
|
-3.20 USD
|
75.625%
|
|
Nuvalent, Inc.
|
-2.17 USD
|
64.055%
|
|
ABVC BioPharma, Inc.
|
-2.43 USD
|
67.901%
|
|
Carisma Therapeutics, Inc.
|
-2.59 USD
|
69.884%
|
|
Unicycive Therapeutics, Inc.
|
-1.28 USD
|
39.063%
|
|
OmniAb, Inc.
|
-0.51 USD
|
-52.941%
|
|
Anew Medical, Inc.
|
0.14 USD
|
657.143%
|
|
Fennec Pharmaceuticals Inc.
|
-0.60 USD
|
-30.0%
|
|
Lipocine Inc.
|
-3.14 USD
|
75.159%
|
|
Lexeo Therapeutics, Inc. Common Stock
|
-2.49 USD
|
68.675%
|
|
Nautilus Biotechnology, Inc.
|
-0.51 USD
|
-52.941%
|
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
89.791%
|
|
G1 Therapeutics, Inc.
|
-0.93 USD
|
16.129%
|
|
Bellerophon Therapeutics, Inc.
|
-2.08 USD
|
62.5%
|
|
Sage Therapeutics, Inc.
|
-9.05 USD
|
91.381%
|
|
Ocugen, Inc.
|
-0.26 USD
|
-200.0%
|
|
Mind Medicine (MindMed) Inc.
|
-2.44 USD
|
68.033%
|
|
Q32 Bio Inc.
|
-35.16 USD
|
97.782%
|
|
Brainstorm Cell Therapeutics Inc.
|
-0.40 USD
|
-95.0%
|
|
Alumis Inc. Common Stock
|
-2.99 USD
|
73.913%
|
|
Equillium, Inc.
|
-0.38 USD
|
-105.263%
|
|
Kyverna Therapeutics, Inc.
|
-0.00 USD
|
-779900.0%
|
|
Coya Therapeutics, Inc.
|
-0.79 USD
|
1.266%
|
|
CNS Pharmaceuticals, Inc.
|
-251.35 USD
|
99.69%
|
|
Galera Therapeutics, Inc.
|
-1.33 USD
|
41.353%
|
|
Evelo Biosciences, Inc.
|
-26.28 USD
|
97.032%
|
|
Comera Life Sciences Holdings, Inc.
|
-1.76 USD
|
55.682%
|
|
Dominari Holdings Inc.
|
-4.38 USD
|
82.192%
|
|
Edesa Biotech, Inc.
|
-2.93 USD
|
73.379%
|
|
vTv Therapeutics Inc.
|
-9.71 USD
|
91.967%
|
|
Bio-Techne Corporation
|
1.07 USD
|
172.897%
|
|
Agios Pharmaceuticals, Inc.
|
-6.33 USD
|
87.678%
|
|
Harmony Biosciences Holdings, Inc.
|
2.17 USD
|
135.945%
|
|
Prelude Therapeutics Incorporated
|
-2.02 USD
|
61.386%
|
|
Candel Therapeutics, Inc.
|
-1.31 USD
|
40.458%
|
|
iTeos Therapeutics, Inc.
|
-3.15 USD
|
75.238%
|
|
Nkarta, Inc.
|
-2.40 USD
|
67.5%
|
|
BioCardia, Inc.
|
-8.19 USD
|
90.476%
|
|
Iterum Therapeutics plc
|
-2.96 USD
|
73.649%
|
